Harpoon Therapeutics Inc
F:5HT
Harpoon Therapeutics Inc
F:5HT
Price:
8.15
EUR
Market Cap:
€208.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Harpoon Therapeutics Inc
F:5HT
|
US |
|
H
|
Harmonic Inc
XMUN:HMC
|
US |
Cash Flow Statement
Cash Flow Statement
Harpoon Therapeutics Inc
Harpoon Therapeutics Inc
Currency: USD
| Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||
| Net Income |
(28)
|
(23)
|
(27)
|
(36)
|
(42)
|
(51)
|
(56)
|
(55)
|
(55)
|
(53)
|
(50)
|
(99)
|
(103)
|
(107)
|
(117)
|
(75)
|
(76)
|
(71)
|
(68)
|
(59)
|
(40)
|
(31)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
5
|
6
|
8
|
9
|
11
|
12
|
13
|
13
|
11
|
10
|
8
|
12
|
1
|
|
| Change in Working Capital |
14
|
13
|
(1)
|
2
|
0
|
5
|
49
|
42
|
93
|
86
|
33
|
80
|
(22)
|
(27)
|
(20)
|
(69)
|
(23)
|
(30)
|
(34)
|
(35)
|
(50)
|
(42)
|
|
| Cash from Operating Activities |
(12)
N/A
|
(8)
+32%
|
(27)
-237%
|
(32)
-19%
|
(39)
-20%
|
(43)
-11%
|
(3)
+93%
|
(8)
-176%
|
43
N/A
|
40
-5%
|
(9)
N/A
|
(9)
-6%
|
(113)
-1 134%
|
(120)
-6%
|
(122)
-1%
|
(129)
-6%
|
(84)
+35%
|
(88)
-4%
|
(89)
-2%
|
(83)
+7%
|
(77)
+8%
|
(69)
+10%
|
|
| Investing Cash Flow | |||||||||||||||||||||||
| Capital Expenditures |
(3)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
|
| Other Items |
7
|
0
|
0
|
(52)
|
(81)
|
(64)
|
(66)
|
(50)
|
(59)
|
(75)
|
(63)
|
(67)
|
41
|
26
|
34
|
105
|
75
|
95
|
90
|
62
|
10
|
3
|
|
| Cash from Investing Activities |
4
N/A
|
(1)
N/A
|
(1)
-25%
|
(52)
-7 812%
|
(83)
-59%
|
(67)
+19%
|
(69)
-3%
|
(53)
+24%
|
(61)
-15%
|
(76)
-25%
|
(64)
+17%
|
(68)
-7%
|
41
N/A
|
26
-36%
|
34
+32%
|
105
+205%
|
74
-29%
|
94
+27%
|
90
-5%
|
62
-31%
|
10
-84%
|
3
-67%
|
|
| Financing Cash Flow | |||||||||||||||||||||||
| Net Issuance of Common Stock |
20
|
20
|
90
|
160
|
161
|
141
|
71
|
1
|
1
|
2
|
5
|
112
|
115
|
115
|
112
|
4
|
1
|
1
|
6
|
7
|
7
|
10
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
24
|
24
|
|
| Other |
0
|
(0)
|
(2)
|
0
|
0
|
(2)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
22
N/A
|
20
-10%
|
88
+340%
|
159
+80%
|
159
+0%
|
139
-13%
|
71
-49%
|
1
-98%
|
1
-18%
|
2
+99%
|
5
+138%
|
113
+2 305%
|
115
+3%
|
115
-1%
|
112
-3%
|
4
-96%
|
1
-69%
|
1
-22%
|
6
+525%
|
32
+405%
|
31
-3%
|
33
+6%
|
|
| Change in Cash | |||||||||||||||||||||||
| Net Change in Cash |
15
N/A
|
12
-21%
|
61
+426%
|
74
+23%
|
37
-50%
|
29
-22%
|
(1)
N/A
|
(60)
-7 763%
|
(17)
+71%
|
(34)
-96%
|
(68)
-98%
|
35
N/A
|
43
+21%
|
20
-52%
|
24
+17%
|
(20)
N/A
|
(9)
+58%
|
8
N/A
|
7
-8%
|
11
+54%
|
(36)
N/A
|
(33)
+7%
|
|
| Free Cash Flow | |||||||||||||||||||||||
| Free Cash Flow |
(14)
N/A
|
(9)
+41%
|
(28)
-224%
|
(33)
-19%
|
(41)
-23%
|
(46)
-14%
|
(6)
+86%
|
(11)
-78%
|
40
N/A
|
39
-2%
|
(9)
N/A
|
(10)
-6%
|
(114)
-1 050%
|
(121)
-6%
|
(122)
-1%
|
(129)
-6%
|
(84)
+35%
|
(88)
-4%
|
(90)
-2%
|
(83)
+7%
|
(77)
+7%
|
(70)
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
